Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where cure choices remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/nuvei-enters-japanese-market-via-paywiser-acquisition/